![](https://investorshub.advfn.com/uicon/250952.png?cb=1618145303)
Sunday, March 12, 2017 12:34:18 PM
PPHM's proof of concept program is in early stage, they released one results and they will need one per market they address. However the first one was BINGO right away because testing in Ovarian, as the PR explained, was a market with a need and PPHM's exosome test had 100% accuracy.
For a partner, that alone, is sufficient. They may close a SMALL partnership and provide mile-stones for the other cancers. Such initial partnership would do it for us.
Furthermore PPHM is developing proof of concepts that will also show the OTHER characteristics of the Exosome blood test. I am not aiming at the CHEAP, FAST and SIMPLE because that a partner can asses based on the first test, as they are all the same but just looking for different molecules depending on the cancer. I am speaking about the the Exosome test properties.
Said 100-200Bil$ market is only for those tests that do them all. And PPHM's test is the ONLY that does.
Furthermore I think that if something would happen tomorrow it would need an UP-FRONT PR of something that will be said during the Q/CC in the evening.
But those that think that only a partnership does the trick for Wall Street, think again. As an example, without that example being a limiting list, the announcement of the HALO/ROCHE production is a money maker. Bringing profitability 3 or 6 months closer (would be kind of End of CALENDAR YEAR), would certainly also not go unnoticed if it is accompanied by a good Avid quarter that full-fills the expectations.
What if the Ronin 13-D and then 13-G filing containing the "wanting to talk to the BoD" were ALREADY a fact. Think, would Roning invest about 25Mil shares in PPHM, clearly being a LONG TERM investment firm with only 4 stocks in portfolio and a tradition of PARTICIPATING (by sitting on the board) in companies start investing IF they didn't UP-FRONT know that they have a chance to have a board seat?
Buy, talk to PPHM, get a NO, then Sell? NO, that is mostly NOT how they do it. Certainly not with a company that has a Poison Pill installed, a Bod that Guards it, and Delaware bylaws that almost give the BoD a license to kill and get away with it? NO WAY. Stafford III knows at this moment if a BoD seat at PPHM is a possibility or totally excluded. With only 4 stocks in portfolio they have all the time to prepare this, hear around, do some informal talks, etc and then work within an EDUCATED frame work.
So what if PPHM announces an extra BoD member that already invested in 25Mil shares, or two BoD member if maybe Dart also wants in, he has MORE then 25Mil shares.
From jakedogman's post:
Stafford (Ronin) was on BOD at Xencor up until Jan 2016 and still owns 7 mil shares...
Xencor has partnerships with the following...
Alexion
CSL-Janssen
Boehringer Ingelheim
Janssen
Merck
Amgen
Novartis
All of them are on the hunt ....
Peregrine Pharmaceuticals the Microsoft of Biotechnology! All In My Opinion. I am not advising anything, nor accusing anyone.
Recent CDMO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:50:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:48:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/15/2024 08:40:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/12/2024 08:30:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:02:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:02:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:01:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:01:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:00:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:00:45 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/11/2024 12:23:26 AM
- Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024 • GlobeNewswire Inc. • 07/02/2024 08:05:04 PM
- Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024 • GlobeNewswire Inc. • 07/01/2024 11:00:21 AM
- Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance • GlobeNewswire Inc. • 05/23/2024 12:05:46 PM
- Avid Bioservices to Participate at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/07/2024 08:05:11 PM
- Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 04/24/2024 09:25:33 PM
- Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q • GlobeNewswire Inc. • 03/20/2024 11:00:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:30:11 AM
- Avid Bioservices Announces Pricing of Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/07/2024 04:58:48 AM
- Avid Bioservices Announces Proposed Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/06/2024 09:32:07 PM
- Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 03/06/2024 09:31:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:30:18 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:57:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 12:34:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:39:18 AM
FEATURED Mawson Finland Provides Update on Exploration Activities at Rajapalot • Aug 21, 2024 9:06 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM
Avant Technologies to Implement Robust Cybersecurity Measures for AI-Driven Healthcare Solutions • AVAI • Aug 21, 2024 8:00 AM
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM